抗毒素血清のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Antivenom Serum Market Insights and Forecast to 2028

• レポートコード：QY2203B09229
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の抗毒素血清の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に抗毒素血清の世界市場のxxx％を占める「人間」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「一価」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の抗毒素血清の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの抗毒素血清市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの抗毒素血清市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

抗毒素血清のグローバル主要メーカーには、Merck、Summerland Serums (AU)、Haffkine Bio Pharmaceutical、MicroPharm、CSL (AU)、SAVP、Flynn Pharma、Serumなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

抗毒素血清市場は、種類と用途によって区分されます。世界の抗毒素血清市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
人間、動物

【用途別セグメント】
一価、多価

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 抗毒素血清製品概要
- 種類別市場（人間、動物）
- 用途別市場（一価、多価）
- 調査の目的
・エグゼクティブサマリー
- 世界の抗毒素血清販売量予測2017-2028
- 世界の抗毒素血清売上予測2017-2028
- 抗毒素血清の地域別販売量
- 抗毒素血清の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別抗毒素血清販売量
- 主要メーカー別抗毒素血清売上
- 主要メーカー別抗毒素血清価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（人間、動物）
- 抗毒素血清の種類別販売量
- 抗毒素血清の種類別売上
- 抗毒素血清の種類別価格
・用途別市場規模（一価、多価）
- 抗毒素血清の用途別販売量
- 抗毒素血清の用途別売上
- 抗毒素血清の用途別価格
・北米市場
- 北米の抗毒素血清市場規模（種類別、用途別）
- 主要国別の抗毒素血清市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの抗毒素血清市場規模（種類別、用途別）
- 主要国別の抗毒素血清市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の抗毒素血清市場規模（種類別、用途別）
- 主要国別の抗毒素血清市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の抗毒素血清市場規模（種類別、用途別）
- 主要国別の抗毒素血清市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの抗毒素血清市場規模（種類別、用途別）
- 主要国別の抗毒素血清市場規模（トルコ、サウジアラビア）
・企業情報
Merck、Summerland Serums (AU)、Haffkine Bio Pharmaceutical、MicroPharm、CSL (AU)、SAVP、Flynn Pharma、Serum
・産業チェーン及び販売チャネル分析
- 抗毒素血清の産業チェーン分析
- 抗毒素血清の原材料
- 抗毒素血清の生産プロセス
- 抗毒素血清の販売及びマーケティング
- 抗毒素血清の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 抗毒素血清の産業動向
- 抗毒素血清のマーケットドライバー
- 抗毒素血清の課題
- 抗毒素血清の阻害要因
・主な調査結果

Market Analysis and Insights: Global Antivenom Serum Market
Due to the COVID-19 pandemic, the global Antivenom Serum market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Humans accounting for % of the Antivenom Serum global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Monovalent segment is altered to an % CAGR throughout this forecast period.
China Antivenom Serum market size is valued at US$ million in 2021, while the US and Europe Antivenom Serum are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Antivenom Serum landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Antivenom Serum include Merck, Summerland Serums (AU), Haffkine Bio Pharmaceutical, MicroPharm, CSL (AU), SAVP, Flynn Pharma and Serum, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Antivenom Serum Scope and Segment
Antivenom Serum market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antivenom Serum market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Humans
Animals
Segment by Application
Monovalent
Polyvalent
By Company
Merck
Summerland Serums (AU)
Haffkine Bio Pharmaceutical
MicroPharm
CSL (AU)
SAVP
Flynn Pharma
Serum
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

1 Study Coverage
1.1 Antivenom Serum Product Introduction
1.2 Market by Type
1.2.1 Global Antivenom Serum Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Humans
1.2.3 Animals
1.3 Market by Application
1.3.1 Global Antivenom Serum Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Monovalent
1.3.3 Polyvalent
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antivenom Serum Sales Estimates and Forecasts 2017-2028
2.2 Global Antivenom Serum Revenue Estimates and Forecasts 2017-2028
2.3 Global Antivenom Serum Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antivenom Serum Sales by Region
2.4.1 Global Antivenom Serum Sales by Region (2017-2022)
2.4.2 Global Sales Antivenom Serum by Region (2023-2028)
2.5 Global Antivenom Serum Revenue by Region
2.5.1 Global Antivenom Serum Revenue by Region (2017-2022)
2.5.2 Global Antivenom Serum Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antivenom Serum Sales by Manufacturers
3.1.1 Global Top Antivenom Serum Manufacturers by Sales (2017-2022)
3.1.2 Global Antivenom Serum Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antivenom Serum in 2021
3.2 Global Antivenom Serum Revenue by Manufacturers
3.2.1 Global Antivenom Serum Revenue by Manufacturers (2017-2022)
3.2.2 Global Antivenom Serum Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antivenom Serum Revenue in 2021
3.3 Global Antivenom Serum Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antivenom Serum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antivenom Serum Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antivenom Serum Sales by Type
4.1.1 Global Antivenom Serum Historical Sales by Type (2017-2022)
4.1.2 Global Antivenom Serum Forecasted Sales by Type (2023-2028)
4.1.3 Global Antivenom Serum Sales Market Share by Type (2017-2028)
4.2 Global Antivenom Serum Revenue by Type
4.2.1 Global Antivenom Serum Historical Revenue by Type (2017-2022)
4.2.2 Global Antivenom Serum Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antivenom Serum Revenue Market Share by Type (2017-2028)
4.3 Global Antivenom Serum Price by Type
4.3.1 Global Antivenom Serum Price by Type (2017-2022)
4.3.2 Global Antivenom Serum Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antivenom Serum Sales by Application
5.1.1 Global Antivenom Serum Historical Sales by Application (2017-2022)
5.1.2 Global Antivenom Serum Forecasted Sales by Application (2023-2028)
5.1.3 Global Antivenom Serum Sales Market Share by Application (2017-2028)
5.2 Global Antivenom Serum Revenue by Application
5.2.1 Global Antivenom Serum Historical Revenue by Application (2017-2022)
5.2.2 Global Antivenom Serum Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antivenom Serum Revenue Market Share by Application (2017-2028)
5.3 Global Antivenom Serum Price by Application
5.3.1 Global Antivenom Serum Price by Application (2017-2022)
5.3.2 Global Antivenom Serum Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antivenom Serum Market Size by Type
6.1.1 North America Antivenom Serum Sales by Type (2017-2028)
6.1.2 North America Antivenom Serum Revenue by Type (2017-2028)
6.2 North America Antivenom Serum Market Size by Application
6.2.1 North America Antivenom Serum Sales by Application (2017-2028)
6.2.2 North America Antivenom Serum Revenue by Application (2017-2028)
6.3 North America Antivenom Serum Market Size by Country
6.3.1 North America Antivenom Serum Sales by Country (2017-2028)
6.3.2 North America Antivenom Serum Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antivenom Serum Market Size by Type
7.1.1 Europe Antivenom Serum Sales by Type (2017-2028)
7.1.2 Europe Antivenom Serum Revenue by Type (2017-2028)
7.2 Europe Antivenom Serum Market Size by Application
7.2.1 Europe Antivenom Serum Sales by Application (2017-2028)
7.2.2 Europe Antivenom Serum Revenue by Application (2017-2028)
7.3 Europe Antivenom Serum Market Size by Country
7.3.1 Europe Antivenom Serum Sales by Country (2017-2028)
7.3.2 Europe Antivenom Serum Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antivenom Serum Market Size by Type
8.1.1 Asia Pacific Antivenom Serum Sales by Type (2017-2028)
8.1.2 Asia Pacific Antivenom Serum Revenue by Type (2017-2028)
8.2 Asia Pacific Antivenom Serum Market Size by Application
8.2.1 Asia Pacific Antivenom Serum Sales by Application (2017-2028)
8.2.2 Asia Pacific Antivenom Serum Revenue by Application (2017-2028)
8.3 Asia Pacific Antivenom Serum Market Size by Region
8.3.1 Asia Pacific Antivenom Serum Sales by Region (2017-2028)
8.3.2 Asia Pacific Antivenom Serum Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antivenom Serum Market Size by Type
9.1.1 Latin America Antivenom Serum Sales by Type (2017-2028)
9.1.2 Latin America Antivenom Serum Revenue by Type (2017-2028)
9.2 Latin America Antivenom Serum Market Size by Application
9.2.1 Latin America Antivenom Serum Sales by Application (2017-2028)
9.2.2 Latin America Antivenom Serum Revenue by Application (2017-2028)
9.3 Latin America Antivenom Serum Market Size by Country
9.3.1 Latin America Antivenom Serum Sales by Country (2017-2028)
9.3.2 Latin America Antivenom Serum Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antivenom Serum Market Size by Type
10.1.1 Middle East and Africa Antivenom Serum Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antivenom Serum Revenue by Type (2017-2028)
10.2 Middle East and Africa Antivenom Serum Market Size by Application
10.2.1 Middle East and Africa Antivenom Serum Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antivenom Serum Revenue by Application (2017-2028)
10.3 Middle East and Africa Antivenom Serum Market Size by Country
10.3.1 Middle East and Africa Antivenom Serum Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antivenom Serum Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Antivenom Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Summerland Serums (AU)
11.2.1 Summerland Serums (AU) Corporation Information
11.2.2 Summerland Serums (AU) Overview
11.2.3 Summerland Serums (AU) Antivenom Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Summerland Serums (AU) Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Summerland Serums (AU) Recent Developments
11.3 Haffkine Bio Pharmaceutical
11.3.1 Haffkine Bio Pharmaceutical Corporation Information
11.3.2 Haffkine Bio Pharmaceutical Overview
11.3.3 Haffkine Bio Pharmaceutical Antivenom Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Haffkine Bio Pharmaceutical Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Haffkine Bio Pharmaceutical Recent Developments
11.4 MicroPharm
11.4.1 MicroPharm Corporation Information
11.4.2 MicroPharm Overview
11.4.3 MicroPharm Antivenom Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MicroPharm Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MicroPharm Recent Developments
11.5 CSL (AU)
11.5.1 CSL (AU) Corporation Information
11.5.2 CSL (AU) Overview
11.5.3 CSL (AU) Antivenom Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CSL (AU) Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CSL (AU) Recent Developments
11.6 SAVP
11.6.1 SAVP Corporation Information
11.6.2 SAVP Overview
11.6.3 SAVP Antivenom Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 SAVP Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 SAVP Recent Developments
11.7 Flynn Pharma
11.7.1 Flynn Pharma Corporation Information
11.7.2 Flynn Pharma Overview
11.7.3 Flynn Pharma Antivenom Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Flynn Pharma Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Flynn Pharma Recent Developments
11.8 Serum
11.8.1 Serum Corporation Information
11.8.2 Serum Overview
11.8.3 Serum Antivenom Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Serum Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Serum Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antivenom Serum Industry Chain Analysis
12.2 Antivenom Serum Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antivenom Serum Production Mode & Process
12.4 Antivenom Serum Sales and Marketing
12.4.1 Antivenom Serum Sales Channels
12.4.2 Antivenom Serum Distributors
12.5 Antivenom Serum Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antivenom Serum Industry Trends
13.2 Antivenom Serum Market Drivers
13.3 Antivenom Serum Market Challenges
13.4 Antivenom Serum Market Restraints
14 Key Findings in The Global Antivenom Serum Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Antivenom Serum Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Humans
Table 3. Major Manufacturers of Animals
Table 4. Global Antivenom Serum Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Antivenom Serum Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Antivenom Serum Sales by Region (2017-2022) & (K Doses)
Table 7. Global Antivenom Serum Sales Market Share by Region (2017-2022)
Table 8. Global Antivenom Serum Sales by Region (2023-2028) & (K Doses)
Table 9. Global Antivenom Serum Sales Market Share by Region (2023-2028)
Table 10. Global Antivenom Serum Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Antivenom Serum Revenue Market Share by Region (2017-2022)
Table 12. Global Antivenom Serum Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Antivenom Serum Revenue Market Share by Region (2023-2028)
Table 14. Global Antivenom Serum Sales by Manufacturers (2017-2022) & (K Doses)
Table 15. Global Antivenom Serum Sales Share by Manufacturers (2017-2022)
Table 16. Global Antivenom Serum Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Antivenom Serum Revenue Share by Manufacturers (2017-2022)
Table 18. Antivenom Serum Price by Manufacturers (2017-2022) &(USD/Dose)
Table 19. Global Antivenom Serum Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Antivenom Serum by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivenom Serum as of 2021)
Table 21. Antivenom Serum Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Antivenom Serum Product Offered
Table 23. Date of Manufacturers Enter into Antivenom Serum Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antivenom Serum Sales by Type (2017-2022) & (K Doses)
Table 26. Global Antivenom Serum Sales by Type (2023-2028) & (K Doses)
Table 27. Global Antivenom Serum Sales Share by Type (2017-2022)
Table 28. Global Antivenom Serum Sales Share by Type (2023-2028)
Table 29. Global Antivenom Serum Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Antivenom Serum Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Antivenom Serum Revenue Share by Type (2017-2022)
Table 32. Global Antivenom Serum Revenue Share by Type (2023-2028)
Table 33. Antivenom Serum Price by Type (2017-2022) & (USD/Dose)
Table 34. Global Antivenom Serum Price Forecast by Type (2023-2028) & (USD/Dose)
Table 35. Global Antivenom Serum Sales by Application (2017-2022) & (K Doses)
Table 36. Global Antivenom Serum Sales by Application (2023-2028) & (K Doses)
Table 37. Global Antivenom Serum Sales Share by Application (2017-2022)
Table 38. Global Antivenom Serum Sales Share by Application (2023-2028)
Table 39. Global Antivenom Serum Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Antivenom Serum Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Antivenom Serum Revenue Share by Application (2017-2022)
Table 42. Global Antivenom Serum Revenue Share by Application (2023-2028)
Table 43. Antivenom Serum Price by Application (2017-2022) & (USD/Dose)
Table 44. Global Antivenom Serum Price Forecast by Application (2023-2028) & (USD/Dose)
Table 45. North America Antivenom Serum Sales by Type (2017-2022) & (K Doses)
Table 46. North America Antivenom Serum Sales by Type (2023-2028) & (K Doses)
Table 47. North America Antivenom Serum Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Antivenom Serum Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Antivenom Serum Sales by Application (2017-2022) & (K Doses)
Table 50. North America Antivenom Serum Sales by Application (2023-2028) & (K Doses)
Table 51. North America Antivenom Serum Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Antivenom Serum Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Antivenom Serum Sales by Country (2017-2022) & (K Doses)
Table 54. North America Antivenom Serum Sales by Country (2023-2028) & (K Doses)
Table 55. North America Antivenom Serum Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Antivenom Serum Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Antivenom Serum Sales by Type (2017-2022) & (K Doses)
Table 58. Europe Antivenom Serum Sales by Type (2023-2028) & (K Doses)
Table 59. Europe Antivenom Serum Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Antivenom Serum Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Antivenom Serum Sales by Application (2017-2022) & (K Doses)
Table 62. Europe Antivenom Serum Sales by Application (2023-2028) & (K Doses)
Table 63. Europe Antivenom Serum Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Antivenom Serum Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Antivenom Serum Sales by Country (2017-2022) & (K Doses)
Table 66. Europe Antivenom Serum Sales by Country (2023-2028) & (K Doses)
Table 67. Europe Antivenom Serum Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Antivenom Serum Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Antivenom Serum Sales by Type (2017-2022) & (K Doses)
Table 70. Asia Pacific Antivenom Serum Sales by Type (2023-2028) & (K Doses)
Table 71. Asia Pacific Antivenom Serum Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Antivenom Serum Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Antivenom Serum Sales by Application (2017-2022) & (K Doses)
Table 74. Asia Pacific Antivenom Serum Sales by Application (2023-2028) & (K Doses)
Table 75. Asia Pacific Antivenom Serum Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Antivenom Serum Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Antivenom Serum Sales by Region (2017-2022) & (K Doses)
Table 78. Asia Pacific Antivenom Serum Sales by Region (2023-2028) & (K Doses)
Table 79. Asia Pacific Antivenom Serum Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Antivenom Serum Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Antivenom Serum Sales by Type (2017-2022) & (K Doses)
Table 82. Latin America Antivenom Serum Sales by Type (2023-2028) & (K Doses)
Table 83. Latin America Antivenom Serum Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Antivenom Serum Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Antivenom Serum Sales by Application (2017-2022) & (K Doses)
Table 86. Latin America Antivenom Serum Sales by Application (2023-2028) & (K Doses)
Table 87. Latin America Antivenom Serum Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Antivenom Serum Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Antivenom Serum Sales by Country (2017-2022) & (K Doses)
Table 90. Latin America Antivenom Serum Sales by Country (2023-2028) & (K Doses)
Table 91. Latin America Antivenom Serum Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Antivenom Serum Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Antivenom Serum Sales by Type (2017-2022) & (K Doses)
Table 94. Middle East and Africa Antivenom Serum Sales by Type (2023-2028) & (K Doses)
Table 95. Middle East and Africa Antivenom Serum Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Antivenom Serum Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Antivenom Serum Sales by Application (2017-2022) & (K Doses)
Table 98. Middle East and Africa Antivenom Serum Sales by Application (2023-2028) & (K Doses)
Table 99. Middle East and Africa Antivenom Serum Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Antivenom Serum Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Antivenom Serum Sales by Country (2017-2022) & (K Doses)
Table 102. Middle East and Africa Antivenom Serum Sales by Country (2023-2028) & (K Doses)
Table 103. Middle East and Africa Antivenom Serum Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Antivenom Serum Revenue by Country (2023-2028) & (US$ Million)
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 108. Merck Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Merck Recent Developments
Table 110. Summerland Serums (AU) Corporation Information
Table 111. Summerland Serums (AU) Description and Major Businesses
Table 112. Summerland Serums (AU) Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Summerland Serums (AU) Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Summerland Serums (AU) Recent Developments
Table 115. Haffkine Bio Pharmaceutical Corporation Information
Table 116. Haffkine Bio Pharmaceutical Description and Major Businesses
Table 117. Haffkine Bio Pharmaceutical Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Haffkine Bio Pharmaceutical Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Haffkine Bio Pharmaceutical Recent Developments
Table 120. MicroPharm Corporation Information
Table 121. MicroPharm Description and Major Businesses
Table 122. MicroPharm Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. MicroPharm Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. MicroPharm Recent Developments
Table 125. CSL (AU) Corporation Information
Table 126. CSL (AU) Description and Major Businesses
Table 127. CSL (AU) Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. CSL (AU) Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. CSL (AU) Recent Developments
Table 130. SAVP Corporation Information
Table 131. SAVP Description and Major Businesses
Table 132. SAVP Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. SAVP Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. SAVP Recent Developments
Table 135. Flynn Pharma Corporation Information
Table 136. Flynn Pharma Description and Major Businesses
Table 137. Flynn Pharma Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. Flynn Pharma Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Flynn Pharma Recent Developments
Table 140. Serum Corporation Information
Table 141. Serum Description and Major Businesses
Table 142. Serum Antivenom Serum Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Serum Antivenom Serum Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Serum Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Antivenom Serum Distributors List
Table 148. Antivenom Serum Customers List
Table 149. Antivenom Serum Market Trends
Table 150. Antivenom Serum Market Drivers
Table 151. Antivenom Serum Market Challenges
Table 152. Antivenom Serum Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivenom Serum Product Picture
Figure 3. Global Antivenom Serum Market Share by Type in 2021 & 2028
Figure 3. Humans Product Picture
Figure 4. Animals Product Picture
Figure 5. Global Antivenom Serum Market Share by Application in 2021 & 2028
Figure 6. Monovalent
Figure 7. Polyvalent
Figure 8. Antivenom Serum Report Years Considered
Figure 9. Global Antivenom Serum Sales 2017-2028 (K Doses)
Figure 10. Global Antivenom Serum Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Antivenom Serum Revenue 2017-2028 (US$ Million)
Figure 12. Global Antivenom Serum Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Antivenom Serum Sales Market Share by Region (2017-2022)
Figure 14. Global Antivenom Serum Sales Market Share by Region (2023-2028)
Figure 15. North America Antivenom Serum Sales YoY (2017-2028) & (K Doses)
Figure 16. North America Antivenom Serum Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Antivenom Serum Sales YoY (2017-2028) & (K Doses)
Figure 18. Europe Antivenom Serum Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Antivenom Serum Sales YoY (2017-2028) & (K Doses)
Figure 20. Asia-Pacific Antivenom Serum Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Antivenom Serum Sales YoY (2017-2028) & (K Doses)
Figure 22. Latin America Antivenom Serum Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Antivenom Serum Sales YoY (2017-2028) & (K Doses)
Figure 24. Middle East & Africa Antivenom Serum Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Antivenom Serum Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Antivenom Serum in the World: Market Share by Antivenom Serum Revenue in 2021
Figure 27. Global Antivenom Serum Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Antivenom Serum Sales Market Share by Type (2017-2028)
Figure 29. Global Antivenom Serum Revenue Market Share by Type (2017-2028)
Figure 30. Global Antivenom Serum Sales Market Share by Application (2017-2028)
Figure 31. Global Antivenom Serum Revenue Market Share by Application (2017-2028)
Figure 32. North America Antivenom Serum Sales Market Share by Type (2017-2028)
Figure 33. North America Antivenom Serum Revenue Market Share by Type (2017-2028)
Figure 34. North America Antivenom Serum Sales Market Share by Application (2017-2028)
Figure 35. North America Antivenom Serum Revenue Market Share by Application (2017-2028)
Figure 36. North America Antivenom Serum Sales Share by Country (2017-2028)
Figure 37. North America Antivenom Serum Revenue Share by Country (2017-2028)
Figure 38. U.S. Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Antivenom Serum Sales Market Share by Type (2017-2028)
Figure 41. Europe Antivenom Serum Revenue Market Share by Type (2017-2028)
Figure 42. Europe Antivenom Serum Sales Market Share by Application (2017-2028)
Figure 43. Europe Antivenom Serum Revenue Market Share by Application (2017-2028)
Figure 44. Europe Antivenom Serum Sales Share by Country (2017-2028)
Figure 45. Europe Antivenom Serum Revenue Share by Country (2017-2028)
Figure 46. Germany Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 47. France Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Antivenom Serum Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Antivenom Serum Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Antivenom Serum Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Antivenom Serum Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Antivenom Serum Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Antivenom Serum Revenue Share by Region (2017-2028)
Figure 57. China Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 60. India Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Antivenom Serum Sales Market Share by Type (2017-2028)
Figure 68. Latin America Antivenom Serum Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Antivenom Serum Sales Market Share by Application (2017-2028)
Figure 70. Latin America Antivenom Serum Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Antivenom Serum Sales Share by Country (2017-2028)
Figure 72. Latin America Antivenom Serum Revenue Share by Country (2017-2028)
Figure 73. Mexico Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Antivenom Serum Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Antivenom Serum Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Antivenom Serum Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Antivenom Serum Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Antivenom Serum Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Antivenom Serum Revenue Share by Country (2017-2028)
Figure 82. Turkey Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Antivenom Serum Revenue (2017-2028) & (US$ Million)
Figure 85. Antivenom Serum Value Chain
Figure 86. Antivenom Serum Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

以下、関連資料のご紹介

パルスチェイス解析のグローバル市場インサイト・予測（～2028年）

Global Pulse-chase Analysis Market Insights, Forecast to 2028
QY2203B04973 2022年3月 79Pages
新型コロナウイルス感染症のパンデミックにより、世界のパルスチェイス解析の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパルスチェイス解析...

過活動膀胱（OAB）治療のグローバル市場インサイト・予測（～2028年）

Global Overactive Bladder Treatment Market Insights and Forecast to 2028
QY2203B08096 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の過活動膀胱（OAB）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に過活動膀胱（...

スピンオンドーパントのグローバル市場インサイト・予測（～2028年）

Global Spin-on Dopant Market Insights, Forecast to 2028
QY2203B03540 2022年3月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界のスピンオンドーパントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスピンオンドーパ...

GaNウェーハ用CMPパッド（GaN基板）のグローバル市場インサイト・予測（～2028年）

Global CMP Pads for GaN Wafer (GaN Substrate) Market Insights, Forecast to 2028
QY2203B00612 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界のGaNウェーハ用CMPパッド（GaN基板）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、202...

遠心蒸発器のグローバル市場インサイト・予測（～2028年）

Global Centrifugal Evaporator Market Insights and Forecast to 2028
QY2203B07767 2022年3月 74Pages
新型コロナウイルス感染症のパンデミックにより、世界の遠心蒸発器の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に遠心蒸発器の世界市場のxx...

ジブチルアミン(DBA)のグローバル市場インサイト・予測（～2028年）

Global Dibutylamine(DBA)(CAS 111-92-2) Market Insights and Forecast to 2028
QY2203B03170 2022年3月 92Pages
新型コロナウイルス感染症のパンデミックにより、世界のジブチルアミン(DBA)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にジブチルアミ...

オーガニックモロッコアルガンオイルのグローバル市場インサイト・予測（～2028年）

Global Organic Morocco Argan Oil Market Insights and Forecast to 2028
QY2203B02034 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界のオーガニックモロッコアルガンオイルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にオ...

医療用PFAのグローバル市場インサイト・予測（～2028年）

Global Medical Grade PFA Market Insights, Forecast to 2028
QY2203B07478 2022年3月 94Pages
新型コロナウイルス感染症のパンデミックにより、世界の医療用PFAの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に医療用PFAの世界市場の...

N-エチルメタベースエステルのグローバル市場インサイト・予測（～2028年）

Global N-Ethyl Meta Base Ester Market Insights and Forecast to 2028
QY2203B00893 2022年3月 71Pages
新型コロナウイルス感染症のパンデミックにより、世界のN-エチルメタベースエステルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にN-エチ...

ハイトロッドのグローバル市場インサイト・予測（～2028年）

Global Height Rods Market Insights, Forecast to 2028
QY2203B04761 2022年3月 93Pages
新型コロナウイルス感染症のパンデミックにより、世界のハイトロッドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にハイトロッドの世界市場の...

ハイトロッドのグローバル市場インサイト・予測（～2028年） A Height Rod is a piece of medical equipment used for measuring human height. It is usually constructed out of a ruler and a sliding horizontal headpiece which is adjusted to rest on the top of the head. Stadiometers are used in routine medical examinations and also clinical tests and experiments. M…
蘇生装置のグローバル市場インサイト・予測（～2028年） A resuscitator is a device using positive pressure to inflate the lungs of an unconscious person who is not breathing, in order to keep them oxygenated and alive. Market Analysis and Insights: Global Resuscitation Devices Market Due to the COVID-19 pandemic, the global Resuscitation Devices market s…
ヒップブレースのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Hip Brace Market Due to the COVID-19 pandemic, the global Hip Brace market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic chan…
ベッドモニタリングシステムのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Bed Monitoring Systems Market Due to the COVID-19 pandemic, the global Bed Monitoring Systems market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully con…
輪状甲状腺切開術シミュレーターのグローバル市場インサイト・予測（～2028年） Cricothyrotomy Simulator is designed for needle or surgical cricothyrotomy. Market Analysis and Insights: Global Cricothyrotomy Simulators Market Due to the COVID-19 pandemic, the global Cricothyrotomy Simulators market size is estimated to be worth US$ million in 2022 and is forecast to a readjuste…